Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Purified human CYP2C19 expressed in E.Coli.|
|Storage buffer||whole serum|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|Functional Assay (FN)||2-20 µl|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
This antibody is a specific and potent inhibitor of CYP2C19 activity.
P450 enzymes are divided into two groups: steroidogenic and Xenobiotic. The latter group is comprised of three families 1 ,2 and 3. The xenobiotic p450's are involved in most oxidative drug metabolism. Work in this area is ongoing but studies suggest that all known drug metabolism is mediated by family members: CYP3a, CYP2D6, CYP2C9/10, CYP2C19, CYP2E1.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
(R)-limonene 6-monooxygenase; (S)-limonene 6-monooxygenase; (S)-limonene 7-monooxygenase; CYPIIC17; CYPIIC19; cytochrome P-450 II C; cytochrome P450 2C19; cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase), polypeptide 19; cytochrome P450-11A; cytochrome P450-254C; flavoprotein-linked monooxygenase; mephenytoin 4'-hydroxylase; mephenytoin 4-hydroxylase; microsomal monooxygenase; S-mephenytoin 4-hydroxylase; xenobiotic monooxygenase
CPCJ; CYP2C; P450C2C; P450IIC19; RP11-400G3.4